Larry B. Honig is a distinguished researcher in neurodegenerative diseases, particularly Alzheimer's disease and frontotemporal dementia (FTD), affiliated with Columbia University in New York City. With an impressive h-index of 100, Dr. Honig is recognized internationally for his contributions to understanding the pathological mechanisms underlying tauopathies and TDP-43 proteinopathies.
Based at Columbia University, one of the world's leading academic medical centers, Dr. Honig leads research programs that bridge basic science discoveries with clinical applications, advancing our understanding of how protein aggregation leads to neuronal dysfunction and death in neurodegenerative diseases.
Dr. Larry B. Honig is based at Columbia University Vagelos College of Physicians and Surgeons, one of the premier institutions for neuroscience research in the world. At Columbia, he holds positions in both the Department of Pathology and Cell Biology and the Department of Neurology, allowing him to bridge pathological investigations with clinical research.
Dr. Honig's research encompasses several interconnected areas:
TDP-43 Pathology: Dr. Honig has been instrumental in characterizing the role of TDP-43 (TAR DNA-binding protein 43) in neurodegenerative diseases. TDP-43 is the primary protein found in inclusions in ALS and the majority of FTD cases, making it a critical target for understanding disease mechanisms.
Tauopathies: His work extends to various tauopathies, including Alzheimer's disease, Progressive Supranuclear Palsy (PSP), and Corticobasal Degeneration (CBD), focusing on how tau protein aggregation drives neurotoxicity.
Clinical-Pathological Correlations: A significant focus involves correlating pathological findings from postmortem brain tissue with clinical presentations, enabling better understanding of disease progression and clinical heterogeneity.
Dr. Honig has made foundational contributions to understanding TDP-43 proteinopathies:
His neuropathology expertise has led to:
Working toward earlier diagnosis, Dr. Honig contributes to:
The study of Larry B. Honig has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.